Clinical Trial

A Study for HSK39775 in Participants With Solid Tumors

Name: A Study for HSK39775 in Participants With Solid Tumors — clinical trial record (NCT06314373)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This research is designed to determine if HSK39775 is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.

Trial Details

NCT Number	NCT06314373
Lead Sponsor	Xizang Haisco Pharmaceutical Co., Ltd
Conditions	Advanced Solid Tumors
Enrollment	243 participants
Start Date	2024-03-07
Primary Completion	2028-02-01 (estimated)
Study Completion	2028-09-01 (estimated)
Updated on ClinicalTrials.gov	2024-03-18